T1	Participants 35 59	malaria chemoprophylaxis
T2	Participants 283 332	group of nonimmune tourists to sub-Saharan Africa
T3	Participants 1445 1501	ge group (below median age 34 y vs median age and above)
T4	Participants 1633 1656	aged 34 years and older
T5	Participants 1825 1887	users of any of the standard malaria chemoprophylaxis regimens
T6	Participants 2101 2119	older counterparts
T7	Participants 1978 2017	younger persons aged less than 34 years
